195 related articles for article (PubMed ID: 19846968)
21. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
Batar B; Güven M; Bariş S; Celkan T; Yildiz I
Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
[TBL] [Abstract][Full Text] [Related]
22. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma.
Chiang FY; Wu CW; Hsiao PJ; Kuo WR; Lee KW; Lin JC; Liao YC; Juo SH
Clin Cancer Res; 2008 Sep; 14(18):5919-24. PubMed ID: 18779313
[TBL] [Abstract][Full Text] [Related]
23. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.
Kim IS; Kim DC; Kim HG; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Kim S; Lee GW
Cancer Genet Cytogenet; 2010 Jan; 196(1):31-7. PubMed ID: 19963133
[TBL] [Abstract][Full Text] [Related]
24. Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations.
Mutlu P; Mutlu M; Yalcin S; Unsoy G; Yaylaci A; Saylam G; Akin I; Korkmaz H; Gunduz U
J BUON; 2015; 20(2):540-7. PubMed ID: 26011347
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms in the hypoxia inducible factor 1-alpha and the impact on the prognosis of early stages of oral cancer.
Muñoz-Guerra MF; Fernández-Contreras ME; Moreno AL; Martín ID; Herráez B; Gamallo C
Ann Surg Oncol; 2009 Aug; 16(8):2351-8. PubMed ID: 19449077
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
[TBL] [Abstract][Full Text] [Related]
27. Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population.
Tae K; Lee HS; Park BJ; Park CW; Kim KR; Cho HY; Kim LH; Park BL; Shin HD
Int J Cancer; 2004 Sep; 111(5):805-8. PubMed ID: 15252855
[TBL] [Abstract][Full Text] [Related]
28. Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.
Lundberg M; Pajusto M; Koskinen WJ; Mäkitie AA; Aaltonen LM; Mattila PS
Head Neck; 2009 May; 31(5):664-72. PubMed ID: 19260117
[TBL] [Abstract][Full Text] [Related]
29. [Validity of chromosome analysis and bleomycin sensitivity assay in the prevention of head and neck cancer in Hungary].
Székely G; Remenár E; Kásler M; Bodrog A; Gundy S
Orv Hetil; 2001 Mar; 142(12):611-6. PubMed ID: 11324219
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer.
Demokan S; Demir D; Suoglu Y; Kiyak E; Akar U; Dalay N
Pathol Oncol Res; 2005; 11(1):22-5. PubMed ID: 15800678
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms and head and neck cancer outcomes: a review.
Hopkins J; Cescon DW; Tse D; Bradbury P; Xu W; Ma C; Wheatley-Price P; Waldron J; Goldstein D; Meyer F; Bairati I; Liu G
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):490-9. PubMed ID: 18349267
[TBL] [Abstract][Full Text] [Related]
32. Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1).
Narter KF; Ergen A; Agaçhan B; Görmüs U; Timirci O; Isbir T
Anticancer Res; 2009 Apr; 29(4):1389-93. PubMed ID: 19414392
[TBL] [Abstract][Full Text] [Related]
33. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
Blessmann M; Pohlenz P; Atac A; Kaifi JT; Eulenburg C; Kalinin V; Merkert P; Smeets R; Heiland M; Blake F; Schmelzle R; Izbicki JR
Int J Oral Maxillofac Surg; 2009 Jul; 38(7):779-84. PubMed ID: 19394797
[TBL] [Abstract][Full Text] [Related]
34. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
36. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
Remenár E
Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of DNA base-excision repair genes APE/Ref-1 and XRCC1 are not associated with the risk for Graves' disease.
Doğru-Abbasoğlu S; Tanrikulu S; Ademoğlu E; Erbil Y; Ozderya A; Karadağ B; Uysal M
Cell Biochem Funct; 2009 Oct; 27(7):462-7. PubMed ID: 19711438
[TBL] [Abstract][Full Text] [Related]
38. GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer.
Csejtei A; Tibold A; Varga Z; Koltai K; Ember A; Orsos Z; Feher G; Horvath OP; Ember I; Kiss I
Anticancer Res; 2008; 28(3B):1917-22. PubMed ID: 18630481
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma.
Hoffmann M; Scheunemann D; Fazel A; Görögh T; Kahn T; Gottschlich S
Oncol Rep; 2009 Mar; 21(3):809-14. PubMed ID: 19212643
[TBL] [Abstract][Full Text] [Related]
40. Role of impaired DNA repair in genotoxic susceptibility of patients with head and neck cancer.
Rusin P; Olszewski J; Morawiec-Bajda A; Przybylowska K; Kaczmarczyk D; Golinska A; Majsterek I
Cell Biol Toxicol; 2009 Oct; 25(5):489-97. PubMed ID: 18787964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
